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GENETIC DISORDERS – DEVELOPMENT
Novel mutation in the nephrin gene of a Japanese patient with
congenital nephrotic syndrome of the Finnish type
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Novel mutation in the nephrin gene of a Japanese patient with Experimental subjects
congenital nephrotic syndrome of the Finnish type. The subject was the third child of healthy consanguine-Background. Congenital nephrotic syndrome (CNS) of the
ous parents. His eldest brother died because of renalFinnish type is a rare autosomal-recessive disorder. Kestila et al
failure at seven months of age. No detailed informationreported that a positionally cloned gene for a novel glomerular
protein nephrin is mutated in CNS. Most Finnish patients have was available on his brother because he was treated in
one of two mutations. In this study, we described a Japanese another hospital, and an autopsy was not performed. His
CNS family associated with a novel missense point mutation second eldest brother died at eight years of age because
in the nephrin gene.
of embryonal rhabdomyosarcoma (RMS) that originatedMethods. Reverse transcription-polymerase chain reaction,
from the right back muscle without infiltrating the kid-polymerase chain reaction, and sequence analysis were used.
ney. The patient was born at 35 gestational weeks andResults. The patient had the three missense mutations homo-
zygously. One mutation was already reported as sequence vari- weighed 2230 g at birth. The placenta weighed 780 g.
ant. The two other novel mutations were the GAG to AAG He was admitted for the treatment of cyanosis and tachy-
transition, leading to a Glu447Lys and the GAC to GTC transi- pnea. At two days of age, he was referred to our depart-tion, predicting an Asp819Val substitution in the nephrin protein.
ment by an obstetrician because of proteinuria and renalConclusion. Our findings indicate that an abnormality of
failure. An initial physical examination revealed a widelynephrin may cause CNS of the Finnish type in Japanese subjects.
opened fontanel (4 3 4 cm), edematous face, deformity
of the thorax, retractive respiration, and undescended
testis. Initial laboratory tests, performed by the clinicalNephrotic syndrome is a very common disease. How-
laboratories at Okayama University Hospital two daysever, its etiology is unclear. Congenital nephrotic syn-
after birth, showed massive poteinuria, hypoproteine-drome (CNS) of the Finnish type (NPHS1) is a rare
mia, hypogammaglobulinemia, and mild renal failure:autosomal-recessive disorder. Kestila et al reported that
total protein 2.97 g/dL, albumin 1.55 g/dL, IgG 298 mg/dL,a positionally cloned gene for a novel glomerular protein
IgA , 7.5 mg/dL, IgM 25.5 mg/dL, creatinine 1.69 mg/dL,nephrin is mutated in CNS [1]. Nephrin is a 1241-residue
blood urea nitrogen 30.0 mg/dL, urinary protein (41),putative transmembrane protein of the immunoglobulin
and urinary occult blood (31) (UROPIECE, Fujisawa,(Ig) family of cell adhesion molecules and is expressed
Japan). The cephalic, cardiac, and abdominal echo-in renal glomeruli, probably mainly in epithelial cells.
graphic findings were normal. Serological tests for syphi-Nephrin may play an important role in development.
lis, cytomegalovirus, and hepatitis B virus were all nega-Many mutations in the nephrin gene were found in
tive. The renal specimen demonstrated proximal tubularFinnish, other European, North African, and North
dilation, glomerular hyalinosis and sclerosis, and slightlyAmerican patients [1, 2]. Interestingly, most Finnish pa-
mesangial hypercellularity. The diagnosis of primarytients have one of two mutations. In this study we de-
CNS was made. At seven months of age, peritoneal dial-scribe a Japanese CNS family associated with a novel
ysis was required.missense point mutation in the nephrin gene.
METHODS
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Total cellular RNA from renal biopsy and enucleatedReceived for publication May 6, 1999
tumor kidney samples, including the sample of the CNSand in revised form August 30, 1999
Accepted for publication September 28, 1999 patient, was isolated by acid-guanidium-phenol-chloro-
form extraction. The isolated RNA was dissolved in di-Ó 2000 by the International Society of Nephrology
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ethylpyrocarbonate-treated water, and the RNA concen-
tration was determined spectrophotometrically at 260 nm
using a Gene Quant RNA/DNA Calculator (Pharmacia,
Cambridge, UK).
Reverse transcription-polymerase chain reaction
Reverse transcription-polymerase chain reaction (RT-
PCR) was performed to examine the expression of the
nephrin mRNA in these samples. One microgram of the
total RNA (the final volume of the reaction was 12.5 mL)
was reverse transcribed using an oligo(dT) primer with
an RT-PCR kit (Stratagene, La Jolla, CA, USA). Fig. 1. Expression of nephrin mRNA. The enucleated tumor kidney
(A) and renal biopsy (B and C ) samples were used for RT-PCR. (D)Two and one half microliters of the first-strand cDNA
HaeIII digest of ØX174 Rf DNA. Products were derived from nephrin
reactions were used for each 50 mL PCR. mRNA (994 bp).
The sequences of the primers were 59CCCTGCCTGA
AAACCTGACG39 (position 107 in cDNA) and 59CGA
CTGGACTTGCTGACACA39 (position 1081 in cDNA).
The PCR reactions were performed with Amplitaq buffer Amp DNA Amplification Reagent Kit (Perkin-Elmer).
(Perkin-Elmer, Branchburg, NJ, USA), 1.5 mmol/L MgCl2, All reactions were performed with 50 ng of DNA, 1.5
0.4 mmol/L of each primer, and 0.5 U of Amplitaq Gold mmol/L MgCl2, and 0.5 mmol/L of each primer in a total
DNA polymerase. The cycle consisted of 958C for 12 volume of 50 mL, and they were performed according
minutes, 958C for 1 minute, 568C for 1 minute, and 728C to the manufacturer’s instructions using a Programmable
for 1.5 minutes, for 45 cycles, followed by a single addi- Thermal Controller (MJ Research, Watertown, MA,
tional 8-minute extension at 728C. The amplified prod- USA). The sequences of the primers were 59AAGAT
ucts contained a 994 bp fragment. The sequences of the GAGGAGGACCAGAGC39 (position 2339 in cDNA)
primers were 59TTTGGCTATCGGGGGCAACC39 (po- and 59AGTGGAGGGTGGCAGAACTG39 (position
sition 1395 in cDNA) and 59CCCCGTTGGTCCCCTG 2568 in cDNA). The cycle consisted of 948C for 4 min-
GATA39 (position 2378 in cDNA). The PCR conditions utes, 948C for 1 minute, 578C for 1 minute, and 728C for
were the same as mentioned earlier in this article. The 1.5 minutes, for 35 cycles, followed by a single additional
amplified products contained a 1002 bp fragment. The 7-minute extension at 728C. The amplified products were
sequences of the primers were 59CCACTGCCGTGCC a 347 bp fragment. After amplification, the PCR products
CGAGGTG39 (position 2583 in cDNA) and 59GGGT were sequenced as described previously in this article.
CCCCAGGCTCCAGACG39 (position 3554 in cDNA). The part of sequence that was not covered by the above-
The PCR reactions were the same as mentioned pre-
mentioned method was determined by a previously de-
viously except for 1.0 mmol/L MgCl2. The annealing tem- scribed method [2].perature was 628C. The amplified products contained a
990 bp fragment. After amplification, 1.5% agarose gel
electrophoresis and staining of the gel with ethidium RESULTS
bromide were performed. The products were also puri-
All kidney samples expressed nephrin mRNA (Fig. 1).
fied by a QIAquick PCR Purification Kit (Qiagen, Hilden,
Moreover, the silent mutation from C to T was foundGermany) for direct double-strand DNA sequencing.
at nucleotide 294 and the mutation from A to G atAutomated DNA sequencing analysis with fluorescent-
nucleotide 426.labeled dideoxy-terminators (ABI PRISM Dye Termi-
The patient had the three missense mutations. The firstnator Cycle Sequencing Ready Reaction Kit; Perkin-
mutation was the GAG to AAG transition, leading to aElmer) was performed according to the manufacturer’s
Glu117Lys. This is likely a common polymorphism [2]. Theinstructions (310 genetic analyzer; Applied Biosystems,
second mutation was also the GAG to AAG transition,Foster City, CA, USA).
leading to a Glu447Lys (Fig. 2). The third mutation was
Polymerase chain reaction and sequence analysis the GAC to GTC transition, predicting an Asp819Val
substitution in the nephrin protein (Fig. 3). The secondThe protocol of this study was approved by the ethical
and third missense mutations were novel, and the analy-committee of Okayama University. Written informed
sis of 21 unrelated normal subjects showed the absenceconsent was obtained from all subjects. Leukocyte DNA
of these two mutations (data not shown).was obtained from each family member, except the pro-
The same heterozygous base changes at codons 447band’s father, and 21 normal subjects using the QIAamp
Blood Kit (Qiagen). PCR was performed using a Gene and 819 were identified in the proband’s mother. No
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Fig. 2. Analysis of nephrin gene exon 11. Automated DNA sequence analysis of the 465 bp PCR products from exon 11 of the proband, showing
a novel homozygous point mutation at codon 447 (GAG to AAG/Glu to Lys), the unaffected mother, showing a heterozygous point mutation,
and the second brother, showing no mutation. The forward sequence in upper panel and the reverse sequence in lower panel are shown.
Fig. 3. Analysis of nephrin gene exon 18. Automated DNA sequence analysis of the 347 bp PCR products from exon 18 of the proband, showing
a novel homozygous point mutation at codon 819 (GAC to GTC/Asp to Val), the unaffected mother, showing a heterozygous point mutation,
and the second brother, showing no mutation. The forward sequence in upper panel and the reverse sequence in lower panel are shown.
mutation was detected in the DNA from the peripheral nephrin gene were detected, including deletions, inser-
tions, nonsense, missense, and splicing mutations in Finn-lymphocytes of the second brother (Figs. 2 and 3).
ish, other European, North African, and North Ameri-
can patients. The typical Finnish mutations are a 2 bp
DISCUSSION deletion in exon 2 and a nonsense mutation in exon 26.
Only one group has been reported previously on the However, these two mutations are rare in other popula-
tions. Most of the 21 missense mutations found weretopic of nephrin [1, 2]. Thirty-six mutations in the
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located in the extracellular domain of nephrin, one in mality of nephrin is not the only cause of NPHS1. It has
also been speculated that an abnormality of not onlythe transmembrane domain, and in the cytosolic domain.
quality but quantity of nephrin, or an abnormality ofExcept for Ser724Cys, which probably causes abnormal
other factors such as the presumptive negative chargeintrachain or interchain disulfide bonds, all mutations in
protein connected to nephrin, or a combination of boththe extracellular domain were within the Ig-like motifs.
abnormalities, causes NPHS1.Nephrin has eight Ig-like motifs in total. Half of the
In this case, three brothers whose parents were cousinsamino acid substitutions occurred in motifs Ig4 (6 muta-
exhibited congenital disease. Interestingly, the secondtions) and Ig7 (5 mutations) [2]. These two motifs may
brother revealed RMS, which appeared to overproducebe more important than other motifs for the function of
IGF2 because of the loss of imprinting [3]. Therefore,nephrin. In our study, a novel mutation, Asp819Val, was
factors other than a mutation of the nephrin gene mayfound within motif Ig7. Moreover, it has been proposed
play a role in its pathogenesis.that the substitution from aspartic acid, which is hydro-
Our findings indicate that an abnormality of nephrinphilic, to valine, which is hydrophobic next to cysteine,
causes congenital nephrotic syndrome of the Finnish typeaffects the conformation of the molecule.
in Japanese subjects.In this study, another novel mutation, Glu447Lys, was
found within motif Ig5. This change is unlikely to affect ACKNOWLEDGMENT
the function of nephrin because both glutamic acid and
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